Sotera Health Company
SHCNASDAQHealthcareDiagnostics & Research
As of Oct 16, 2026 close
- Market cap
- $5.21B
- P/E (TTM)
- 31.85
- Forward P/E
- 15.89
- Dividend yield
- -
- 52-week range
- $13.09$19.85
- Volume (live)
- -
- Avg. volume (3M)
- 1.97M
Sotera Health Company (SHC) Stock Price & Financial Analysis
Sotera Health Company Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $17.79 - $18.52 |
|---|---|
| 52-Week High | $19.85 |
| 52-Week Low | $13.09 |
| Open | $18.13 |
| Volume (last close) | 1.86M |
| Average Volume (3M) | 1.97M |
| Revenue (TTM) | 1.22B |
|---|---|
| Net Income (TTM) | 163.48M |
| Free Cash Flow (TTM) | 112.70M |
| EPS (TTM) | $0.57 |
| Profit Margin | 13.44% |
| Operating Margin | 33.71% |
| Return on Equity (ROE) | 24.56% |
| Debt to Equity | 3.21 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Market Cap | 5.21B |
|---|---|
| Shares Outstanding | 288.15M |
| P/E Ratio (TTM) | 31.85 |
| Forward P/E | 15.89 |
| Price to Sales (P/S) | 4.28 |
| Price to Book (P/B) | 7.82 |
| EV/EBITDA | 13.16 |
| 50-Day MA | $18.69 |
|---|---|
| 200-Day MA | $17.02 |
| 1-Year Change | +11.82% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
Sotera Health Company at a Glance
As of the Oct 16, 2026 close, Sotera Health Company (SHC) has a market capitalization of $5.21B. The stock trades at 31.9× trailing earnings, 15.9× forward earnings and 4.3× sales. Over the trailing twelve months it earned $163.48M on revenue of $1.22B (a 13.4% profit margin) and generated $112.70M of free cash flow. Revenue grew 8.2% year over year.
As of its latest reported balance sheet, it holds $356.72M in cash and securities against $2.14B of debt, a net debt position of $1.78B.
Sotera Health Company does not currently pay a dividend.
The share price is up 11.8% over the past year. At $17.89 (the Oct 16, 2026 close) it sits within its 52-week range of $13.09 to $19.85, above its 200-day moving average of $17.02.
Based on 8 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $22.71, 26.9% above the Oct 16, 2026 close.
Frequently Asked Questions About Sotera Health Company
What is the current stock price for SHC?
As of the Oct 16, 2026 close, SHC stock trades at $17.89. The 52-week range is $13.09–$19.85, with a day range of $17.79–$18.52.
What is the P/E ratio for SHC?
As of the Oct 16, 2026 close, Sotera Health Company's trailing twelve-month (TTM) P/E ratio is 31.9, meaning investors pay $31.9 for every $1 of annual earnings. The forward P/E is 15.9, reflecting analyst expectations for future earnings. Sotera Health Company operates in the Healthcare sector.
Does SHC pay dividends?
Sotera Health Company does not currently pay a regular dividend. The company retains its earnings to reinvest in the business. Check the Dividends tab for historical dividend information.
What do analysts recommend for SHC?
Based on ratings from 8 professional analysts over the last 90 days, the consensus for SHC is Buy. The average 12-month price target is $22.71, a 26.9% upside from the Oct 16, 2026 close of $17.89.
What is the market cap of SHC?
As of the Oct 16, 2026 close, Sotera Health Company's market capitalization is $5.15B, classifying it as a mid-cap company. Sotera Health Company operates in the Healthcare sector within the Diagnostics & Research industry.